Charity Parkinson’s UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson’s and slow down the progression of the condition. Building on recent discoveries that show a direct link between mitochondrial dysfunction and the loss of dopamine cells, Parkinson’s UK will […]